Table 3.

Published Evidence About Topical Therapies for Uveitic Macular Oedema

Generic	Concentration	Preservative-Free	Type of Medication	Propietary	Level of Evidence
Difluprednate	0.05%	No	Topical steroid	Durezol® Diflucor® Flupred®	Case series reporting good effect46,78,88–90
Nepafenac	0.1%	No	Topical NSAIDs	Nevanac®	Case series, limited conflicting evidence. Controlled prospective studies required47,91
Bromfenac	0.09%	No	Topical NSAIDs	Yellox®	Case series, limited conflicting evidence, Controlled prospective studies required51,92
Diclofenac sodium	0.1%	Yes	Topical NSAIDs	Voltarol® Ophtha	No published evidence for uveitic macular oedema Evidence only (randomized control trial) for post-operative macular oedema93
Ketorolac trometamol	0.5%	No	Topical NSAIDs	Acular®	No published evidence for uveitic macular oedema Evidence only (randomized control trial and randomized, investigator-masked, multi-centre clinical trial) for post-operative macular oedema.94,95
Dorzolamide hydrochloride	2%	No	Topical NSAIDs	Trusopt®	No published evidence for uveitic macular oedema Evidence (case series) for post-operative macular oedema95 and for macular oedema associated with retinitis pigmentosa (Case reports;88–90 Prospective non-randomized trial96)